Desq Long
Sign in

Company

Veradermics, Inc

MANE · CIK 0001827635

SEC FORM 4
$0.00

Veradermics, Inc (MANE)

Acquisition (code A) of 9,650 shares at $0 per share.

Reporting Person Hollander David · Officer Title Chief R&D Officer · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001628280-26-060491 · filed 2026-09-03 · View filing →

SEC FORM 4
—

Veradermics, Inc (MANE)

Acquisition (code X) of 149,000 shares; price not stated (see filing).

Reporting Persons MONTANOVA CAPITAL, LLC · Cowen Aaron · Averill Master Fund, Ltd. · Averill Madison Master Fund, Ltd. · Transaction Code X

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0000899140-26-000947 · filed 2026-08-21 · View filing →

SEC FORM 4
—

Veradermics, Inc (MANE)

Acquisition (code X) of 151,000 shares; price not stated (see filing).

Reporting Persons MONTANOVA CAPITAL, LLC · Cowen Aaron · Averill Master Fund, Ltd. · Averill Madison Master Fund, Ltd. · Transaction Code X

Traded Aug 20, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0000899140-26-000947 · filed 2026-08-21 · View filing →

SEC FORM 4
$74,066,957.25

Veradermics, Inc (MANE)

Sale of 690,601 shares at $107.25 per share.

Reporting Persons MONTANOVA CAPITAL, LLC · Cowen Aaron · Averill Master Fund, Ltd. · Averill Madison Master Fund, Ltd. · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0000899140-26-000947 · filed 2026-08-21 · View filing →

SEC FORM 4
$6,370,542.75

Veradermics, Inc (MANE)

Sale of 59,399 shares at $107.25 per share.

Reporting Persons MONTANOVA CAPITAL, LLC · Cowen Aaron · Averill Master Fund, Ltd. · Averill Madison Master Fund, Ltd. · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0000899140-26-000947 · filed 2026-08-21 · View filing →

SEC FORM 4
$42,079.88

Veradermics, Inc (MANE)

Acquisition (code M) of 3,452 shares at $12.19 per share.

Reporting Person Waldman Reid Alexander · Officer Title Chief Executive Officer · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057813 · filed 2026-08-18 · View filing →

SEC FORM 4
$1,230,161.44

Veradermics, Inc (MANE)

Sale of 11,527 shares at $106.72 per share.

Reporting Person Waldman Reid Alexander · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057813 · filed 2026-08-18 · View filing →

SEC FORM 4
$2,713,412.02

Veradermics, Inc (MANE)

Sale of 25,234 shares at $107.53 per share.

Reporting Person Waldman Reid Alexander · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057813 · filed 2026-08-18 · View filing →

SEC FORM 4
$2,981,290.50

Veradermics, Inc (MANE)

Sale of 27,490 shares at $108.45 per share.

Reporting Person Waldman Reid Alexander · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057813 · filed 2026-08-18 · View filing →

SEC FORM 4
$328,140.00

Veradermics, Inc (MANE)

Sale of 3,000 shares at $109.38 per share.

Reporting Person Waldman Reid Alexander · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057813 · filed 2026-08-18 · View filing →

SEC FORM 4
$27,708.72

Veradermics, Inc (MANE)

Sale of 249 shares at $111.28 per share.

Reporting Person Waldman Reid Alexander · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057813 · filed 2026-08-18 · View filing →

SEC FORM 4
$42,079.88

Veradermics, Inc (MANE)

Acquisition (code M) of 3,452 shares at $12.19 per share.

Reporting Person Durso Timothy August · Officer Title Chief Technical Officer · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057816 · filed 2026-08-18 · View filing →

SEC FORM 4
$844,929.78

Veradermics, Inc (MANE)

Sale of 7,918 shares at $106.71 per share.

Reporting Person Durso Timothy August · Officer Title Chief Technical Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057816 · filed 2026-08-18 · View filing →

SEC FORM 4
$1,753,221.12

Veradermics, Inc (MANE)

Sale of 16,306 shares at $107.52 per share.

Reporting Person Durso Timothy August · Officer Title Chief Technical Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057816 · filed 2026-08-18 · View filing →

SEC FORM 4
$1,817,207.46

Veradermics, Inc (MANE)

Sale of 16,767 shares at $108.38 per share.

Reporting Person Durso Timothy August · Officer Title Chief Technical Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057816 · filed 2026-08-18 · View filing →

SEC FORM 4
$256,730.32

Veradermics, Inc (MANE)

Sale of 2,348 shares at $109.34 per share.

Reporting Person Durso Timothy August · Officer Title Chief Technical Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057816 · filed 2026-08-18 · View filing →

SEC FORM 4
$17,916.08

Veradermics, Inc (MANE)

Sale of 161 shares at $111.28 per share.

Reporting Person Durso Timothy August · Officer Title Chief Technical Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057816 · filed 2026-08-18 · View filing →

SEC FORM 4
$1,592,100.00

Veradermics, Inc (MANE)

Sale of 15,000 shares at $106.14 per share.

Reporting Person CHILDS JOHN W · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001628280-26-057196 · filed 2026-08-14 · View filing →

SEC FORM 4
$8,578,400.00

Veradermics, Inc (MANE)

Sale of 80,000 shares at $107.23 per share.

Reporting Person CHILDS JOHN W · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001628280-26-057196 · filed 2026-08-14 · View filing →

SEC FORM 4
$541,200.00

Veradermics, Inc (MANE)

Sale of 5,000 shares at $108.24 per share.

Reporting Person CHILDS JOHN W · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001628280-26-057196 · filed 2026-08-14 · View filing →